Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT

Series of three studies (RCT [861 babies], economic evaluation and generalisability analysis) found no evidence of benefit or harm for peripherally inserted central venous catheters impregnated with rifampicin–miconazole during neonatal care, hence deemed not cost-effective.

Source:

National Institute for Health Research